- Offers broad coverage that is applicable to audiences in various area of cancer research - population studies, diagnostics, prognosis, prediction, therapy, risk, etc.
- Provides critical review analysis of the topics that will clarify and delineate the potential roles of epigenetic signatures in cancer management
- Covers basic, as well as, clinical areas of epigenetic mechanisms in tumorigenesis
- Features contributions by leading experts in the field
- Provides comprehensive coverage of current epigenetic signatures involved in the etiology of various cancers and miRNAs
1. Epigenetic Regulation in Pediatric Leukemia 2. Role of Epigenetics in testicular cancer 3. Changes in the epigenetic landscape of prostate cancer 4. Epigenetic health disparities and colon cancer 5. Genetic and epigenetic modifications in pancreatic cancer 6. Epigenetics of Breast Cancer 7. Epigenetic Modulations in Ovarian Cancer 8. Epigenetic Epidemiology for Cancer Risk 9. Epigenetic biomarkers in cancer epidemiology 10. Epigenetic biomarkers and racial differences in cancer 11. Epigenetic predictive biomarkers 12. Epigenetic signatures in the diagnosis and prognosis of cancer 13. Future Challenges and Prospects for the role of epigenetic mechanism in cancer management
Dr. Saldanha is an Assistant Professor in the Department of Biological Sciences at Alabama State University. Her current research project includes the therapeutic role of histone deacetylase inhibitors in colon and prostate cancers, and her areas of epigenetic interest include epigenetic markers as effective tools in cancer diagnosis. She has more than fifteen years of research experience in cancer epigenetics, protein biochemistry, molecular biology and cloning. She has twelve years of teaching experience and has been a STEM faculty mentor, MARC mentor, and Honor's program project director at ASU. Recently, Dr. Saldanha was named the 2015 National Academies Education Fellow in Life Sciences. She is also currently a Health Disparities Research and Training Program Scholar at UAB and a member of the Cancer Biology Research and Training program at ASU, which was established in 2015. She serves as senior personnel for the ASU-UAB Comprehensive Cancer Center partnership and has been instrumental in developing a cancer biology course at ASU.